Citation: | FANG Ru-meng, DI Ning-ning, ZHENG Qian-qian, XIE Chang-hao, LI Zhi-jun. Relationship between serum B-cell activating factor expression and carotid atherosclerosis and its related factors in patients with systemic lupus erythematosus[J]. Chinese Journal of General Practice, 2022, 20(3): 371-374. doi: 10.16766/j.cnki.issn.1674-4152.002355 |
[1] |
LI D, YOSHIDA K, FELDMAN C H, et al. Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus[J]. Rheumatology(Oxford), 2020, 59(3): 495-504. doi: 10.1093/rheumatology/kez288
|
[2] |
谢长好, 李志军. 系统性红斑狼疮的诊断与治疗[J]. 中华全科医学, 2020, 18(4): 527-528. http://www.zhqkyx.net/article/id/240c4592-9f47-4c70-a324-2bf8221505c8
XIE C H, LI Z J. Diagnosis and treatment of systemic lupus erythematosus[J]. Chinese Journal of General Practice, 2020, 18(4): 527-528. http://www.zhqkyx.net/article/id/240c4592-9f47-4c70-a324-2bf8221505c8
|
[3] |
CINOKU I I, MAVRAGANI C P, MOUTSOPOULOS H M. Atherosclerosis: Beyond the lipid storage hypothesis. The role of autoimmunity[J]. Eur J Clin Invest, 2020, 50(2): e13195.
|
[4] |
穆怀玉, 郭晓辰, 陈馨浓, 等. 动脉粥样硬化中适应性免疫应答的研究进展[J]. 生物化学与生物物理进展, 2020, 47(5): 407-417. https://www.cnki.com.cn/Article/CJFDTOTAL-SHSW202005004.htm
MU H Y, GUO X C, CHEN X N, et al. Advances of adaptive immune response in atherosclerosis[J]. Progress In Biochemistry and Biophysics, 2020, 47(5): 407-417. https://www.cnki.com.cn/Article/CJFDTOTAL-SHSW202005004.htm
|
[5] |
MAGALLARES B, LOBO-PRAT D, CASTELLVÍ I, et al. Assessment of EULAR/ACR-2019, SLICC-2012 and ACR-1997 classification criteria in SLE with longstanding disease[J]. J Clin Med, 2021, 10(11): 2377. doi: 10.3390/jcm10112377
|
[6] |
伍满燕, 梁文卿, 陈江天, 等. 颈动脉粥样硬化性疾病的诊治进展[J]. 中华老年心脑血管病杂志, 2019, 21(11): 1223-1226. doi: 10.3969/j.issn.1009-0126.2019.11.028
WU M Y, LIANG W Q, CHEN J T, et al. Advances in diagnosis and treatment of carotid atherosclerotic diseases[J]. Chinese Journal of Geriatric Heart Brain and Vessel Diseases, 2019, 21(11): 1223-1226. doi: 10.3969/j.issn.1009-0126.2019.11.028
|
[7] |
GIANNELOU M, MAVRAGANI C P. Cardiovascular disease in systemic lupus erythematosus: A comprehensive update[J]. J Autoimmun, 2017, 82: 1-12. doi: 10.1016/j.jaut.2017.05.008
|
[8] |
GATTO M, ZEN M, IACCARINO L, et al. New therapeutic strategies in systemic lupus erythematosus management[J]. Nat Rev Rheumatol, 2019, 15(1): 30-48. doi: 10.1038/s41584-018-0133-2
|
[9] |
ZHU Y H, XIAN X M, WANG Z Z, et al. Research progress on the relationship between atherosclerosis and Inflammation[J]. Biomolecules, 2018, 8(3): 80. doi: 10.3390/biom8030080
|
[10] |
CHISTIAKOV D A, MELNICHENKO A A, GRECHKO A V, et al. Potential of anti-inflammatory agents for treatment of atherosclerosis[J]. Exp Mol Pathol, 2018, 104(2): 114-124. doi: 10.1016/j.yexmp.2018.01.008
|
[11] |
邹钰钿, 张艳林, 曹勇军. B细胞调控动脉粥样硬化性卒中研究进展[J]. 中国现代神经疾病杂志, 2020, 20(1): 15-21. https://www.cnki.com.cn/Article/CJFDTOTAL-XDJB202001009.htm
ZOU Y D, ZHANG Y L, CAO Y J. Progress in the regulation of B cells in atherosclerotic stroke[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2020, 20(1): 15-21. https://www.cnki.com.cn/Article/CJFDTOTAL-XDJB202001009.htm
|
[12] |
FRIEBUS-KARDASH J, BRANCO L, RIBI C, et al. Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosus[J]. Nephrol Dial Transplant, 2018, 33(1): 54-64. doi: 10.1093/ndt/gfx220
|
[13] |
THEODOROU E, NEZOS A, ANTYPA E, et al. B-cell activating factor and related genetic variants in lupus related atherosclerosis[J]. J Autoimmun, 2018, 92: 87-92. https://www.sciencedirect.com/science/article/pii/S0896841118301987
|
[14] |
MÖCKEL T, BASTA F, WEINMANN-MENKE J, et al. B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in systemic lupus erythematosus (SLE)[J]. Autoimmun Rev, 2021, 20(2): 102736.
|
[15] |
GANJALI S, SHIRMOHAMMADI L, READ M I, et al. High-density lipoprotein functionality in systemic lupus erythematosus[J]. Semin Arthritis Rheum, 2020, 50(4): 769-775.
|
[16] |
ZAKI D, AYOUB N M, MOHAMMED Z A Z, et al. Study of B cell activating factor (BAFF) and BAFF-R in systemic lupus erythematosus patients[J]. Am J Med Sci, 2019, 9(6): 203-209. http://www.sapub.org/global/showpaperpdf.aspx?doi=10.5923/j.ajmms.20190906.06
|
[17] |
郭芝璇, 艾雪忱, 唐增奇, 等. 外周血BAFF及Bregs水平与系统性红斑狼疮病情相关性研究[J]. 皮肤性病诊疗学杂志, 2020, 27(2): 65-71. https://www.cnki.com.cn/Article/CJFDTOTAL-LPFZ202002002.htm
GUO Z X, AI X C, TANG Z Q, et al. The levels of BAFF and regulatory B cells and their association with systemic lupus erythematosus[J]. Journal of Diagnosis and Therapy on Dermato-venereology, 2020, 27(2): 65-71. https://www.cnki.com.cn/Article/CJFDTOTAL-LPFZ202002002.htm
|
[18] |
DHAMODHARAN U, TEENA R, KUMAR R V, et al. Circulatory levels of B-cell activating factor of the TNF family in patients with diabetic foot ulcer: Association with disease progression[J]. Wound Repair Regen, 2019, 27(5): 442-449.
|